OM
Opaleye Management Portfolio holdings
AUM
$758M
1-Year Est. Return
77.59%
This Fund
S&P 500
1 Year Est. Return
+77.59%
AUM
$758M
AUM Growth
+$50.6M
(+7.1%)
Holding
64
Top Buys
| 1 | +$42.2M | |
| 2 | +$15M | |
| 3 | +$12.4M | |
| 4 |
Sol-Gel Technologies
SLGL
|
+$9.61M |
| 5 |
UroGen Pharma
URGN
|
+$5.82M |
Top Sells
| 1 | +$37.3M | |
| 2 | +$14M | |
| 3 | +$12.2M | |
| 4 |
Sarepta Therapeutics
SRPT
|
+$11.3M |
| 5 |
Larimar Therapeutics
LRMR
|
+$10.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Harrow
HROW
$1.41B
| $191M | 25.25% |
3,905,000
|
|
||
2
Liquidia Corp
LQDA
$3.41B
| $85M | 11.21% |
2,435,000
-180,000
|
|
||
3
Eton Pharmaceutcials
ETON
$740M
| $48.4M | 6.38% |
2,860,000
|
|
||
4
Rhythm Pharmaceuticals
RYTM
$5.96B
| $35.3M | 4.66% |
330,000
-131,700
|
|
||
5
Apogee Therapeutics
APGE
$6.44B
| $29.3M | 3.87% |
388,257
+25,000
|
|
||
|
SNWV
6
SANUWAVE Health Inc
SNWV
$150M
| $29.3M | 3.86% |
981,267
+1,267
|
|
||
7
Stoke Therapeutics
STOK
$2.12B
| $22.1M | 2.91% |
695,000
+12,983
|
|
||
8
Ocular Therapeutix
OCUL
$1.91B
| $19.4M | 2.55% |
1,595,000
|
|
||
|
9
Sol-Gel Technologies
SLGL
$248M
| $19.1M | 2.52% |
453,739
+248,904
|
|
||
10
CG Oncology
CGON
$5.68B
| $17M | 2.25% |
410,000
|
|
||
11
TG Therapeutics
TGTX
$5.52B
| $15.9M | 2.1% |
535,000
|
|
||
12
Disc Medicine
IRON
$2.69B
| $15.9M | 2.1% |
200,000
+6,227
|
|
||
13
Rezolute
RZLT
$340M
| $14.8M | 1.96% |
6,287,156
+5,383,714
|
|
||
|
CBIO
14
Crescent Biopharma
CBIO
$594M
| $14M | 1.84% |
+1,178,300
|
|
||
15
Alkermes
ALKS
$5.55B
| $13.7M | 1.81% |
490,000
+40,000
|
|
||
|
ACOG
16
Alpha Cognition
ACOG
$131M
| $13.5M | 1.78% |
2,070,784
+1,955,642
|
|
||
17
Annexon
ANNX
$939M
| $13.1M | 1.72% |
2,600,000
|
|
||
18
Edgewise Therapeutics
EWTX
$3.56B
| $12.4M | 1.64% |
500,000
|
|
||
19
Codexis
CDXS
$215M
| $11.1M | 1.46% |
6,789,738
-6,005,262
|
|
||
20
Protagonist Therapeutics
PTGX
$6.68B
| $9.17M | 1.21% |
105,000
|
|
||
21
Gossamer Bio
GOSS
$101M
| $8.43M | 1.11% |
2,720,000
-5,000
|
|
||
|
MBX
22
MBX Biosciences
MBX
$1.56B
| $8.2M | 1.08% |
260,000
+7,000
|
|
||
23
Revolution Medicines
RVMD
$29.1B
| $7.96M | 1.05% |
100,000
|
|
||
24
Xoma
XOMA
$470M
| $7.78M | 1.03% |
292,590
+37,503
|
|
||
25
Journey Medical
DERM
$144M
| $7.52M | 0.99% |
975,000
+3,936
|
|